Institution
Hofstra University
Education•Hempstead, New York, United States•
About: Hofstra University is a education organization based out in Hempstead, New York, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 6341 authors who have published 11896 publications receiving 268028 citations.
Topics: Population, Medicine, Health care, Poison control, Cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The authors explored faculty perspectives on the usefulness of student ratings for formative and summative purposes, and the actual use of student rating for summative evaluation, and found that student ratings are actually being used for the latter purpose.
Abstract: Student ratings of instruction have been the subject of numerous studies with much of the research focusing on the validity and reliability of the ratings themselves Comparatively little empirical investigation has been devoted to the perceptions of the individuals who are the subjects of the ratings, that is, the faculty The current study explored faculty perspectives on the usefulness of student ratings for formative and summative purposes, and the actual use of student ratings for summative purposes Contrary to what might have been deduced from the anecdotal literature, the results of this study do not portray a great deal of resistance to student ratings in general or to their use for formative and summative evaluation It was also found that student ratings are actually being used for the latter purpose The usefulness of the student feedback was viewed differentially by the faculty, with feedback on their interaction with students seen as most useful, followed by feedback on their grading practices, global ratings of instructor and course, and finally structural issues of the course
119 citations
••
King's College London1, South London and Maudsley NHS Foundation Trust2, Carlos III Health Institute3, University of Barcelona4, University of Padua5, Katholieke Universiteit Leuven6, Federal University of Ceará7, Royal College of Surgeons in Ireland8, University of Leicester9, Kyambogo University10, Hofstra University11
TL;DR: This large multinational study demonstrates that physical health multimorbidity is increased across the psychosis-spectrum, and was increased in subclinical and established psychosis in all age ranges (18–44, 45–64, ≥ 65 years).
Abstract: In people with psychosis, physical comorbidities, including cardiovascular and metabolic diseases, are highly prevalent and leading contributors to the premature mortality encountered. However, little is known about physical health multimorbidity in this population or in people with subclinical psychosis and in low- and middle-income countries (LMICs). This study explores physical health multimorbidity patterns among people with psychosis or subclinical psychosis. Overall, data from 242,952 individuals from 48 LMICs, recruited via the World Health Survey, were included in this cross-sectional study. Participants were subdivided into those (1) with a lifetime diagnosis of psychosis (“psychosis”); (2) with more than one psychotic symptom in the past 12 months, but no lifetime diagnosis of psychosis (“subclinical psychosis”); and (3) without psychotic symptoms in the past 12 months or a lifetime diagnosis of psychosis (“controls”). Nine operationalized somatic disorders were examined: arthritis, angina pectoris, asthma, diabetes, chronic back pain, visual impairment, hearing problems, edentulism, and tuberculosis. The association between psychosis and multimorbidity was assessed by multivariable logistic regression analysis. The prevalence of multimorbidity (i.e., two or more physical health conditions) was: controls = 11.4% (95% CI, 11.0–11.8%); subclinical psychosis = 21.8% (95% CI, 20.6–23.0%), and psychosis = 36.0% (95% CI, 32.1–40.2%) (P < 0.0001). After adjustment for age, sex, education, country-wise wealth, and country, subclinical psychosis and psychosis were associated with 2.20 (95% CI, 2.02–2.39) and 4.05 (95% CI, 3.25–5.04) times higher odds for multimorbidity. Moreover, multimorbidity was increased in subclinical and established psychosis in all age ranges (18–44, 45–64, ≥ 65 years). However, multimorbidity was most evident in younger age groups, with people aged 18–44 years with psychosis at greatest odds of physical health multimorbidity (OR = 4.68; 95% CI, 3.46–6.32). This large multinational study demonstrates that physical health multimorbidity is increased across the psychosis-spectrum. Most notably, the association between multimorbidity and psychosis was stronger among younger adults, thus adding further impetus to the calls for the early intervention efforts to prevent the burden of physical health comorbidity at later stages. Urgent public health interventions are necessary not only for those with a psychosis diagnosis, but also for subclinical psychosis to address this considerable public health problem.
119 citations
01 Jan 1986
118 citations
••
TL;DR: Behavioral treatment of body dysmorphic disorder (BDD) patients who received exposure, response prevention, and cognitive therapy may be a suitable treatment approach for BDD.
117 citations
••
TL;DR: This review should be used both as a summary source in placing mitochondrial physiology within the context of acute illness and as a focal point for addressing new research into diagnostic and treatment opportunities these insights provide.
Abstract: Mitochondria are an essential part of the cellular infrastructure, being the primary site for high-energy adenosine triphosphate production through oxidative phosphorylation. Clearly, in severe systemic inflammatory states, like sepsis, cellular metabolism is usually altered, and end organ dysfunction is not only common, but also predictive of long-term morbidity and mortality. Clearly, interest is mitochondrial function both as a target for intracellular injury and response to extrinsic stress have been a major focus of basic science and clinical research into the pathophysiology of acute illness. However, mitochondria have multiple metabolic and signaling functions that may be central in both the expression of sepsis and its ultimate outcome. In this review, the authors address five primary questions centered on the role of mitochondria in sepsis. This review should be used both as a summary source in placing mitochondrial physiology within the context of acute illness and as a focal point for addressing new research into diagnostic and treatment opportunities these insights provide.
117 citations
Authors
Showing all 6443 results
Name | H-index | Papers | Citations |
---|---|---|---|
Kevin J. Tracey | 138 | 561 | 82791 |
David B. Allison | 129 | 836 | 69697 |
John M. Kane | 125 | 752 | 60886 |
Peter K. Gregersen | 124 | 451 | 60278 |
Daniel E. Singer | 123 | 445 | 64998 |
Kenneth L. Davis | 113 | 622 | 61120 |
Michael L. Blute | 112 | 527 | 45296 |
David B. Tanner | 110 | 611 | 72025 |
Bertram Pitt | 107 | 754 | 78458 |
John D. Reveille | 102 | 519 | 38105 |
Christoph U. Correll | 100 | 755 | 37523 |
Robert G. Maki | 100 | 416 | 39234 |
Louis R. Kavoussi | 95 | 544 | 31830 |
Howard Leventhal | 89 | 268 | 29144 |
Allan H. Young | 89 | 700 | 47369 |